e-SPACE Cardio-Renal-Metabolic 2023

Published: 25 March 2023

  • Views:

    Views Icon 12615

  • Likes:

    Heart Icon 7
  • episode_image
    58m 8s
    Part 1 | Session 1 Plenary session 1 – HFpEF Andrew JS Coats, Giuseppe Rosano, Eberhard Standl, María José Soler, Stefan Anker
Average (ratings)
No ratings
Your rating

Overview

e-SPACE Cardio-Renal-Metabolic 2023 was the third edition of the annual global online conference that explores how leading experts, in cardiology, nephrology, and diabetology, are treating the interrelated diseases.

 

Course leadership Prof Stefan Anker (Berlin, DE), Dr Javed Butler (Texas, US), Prof Antonio Ceriello (Milan, IT), Prof Tara I Chang (California, US), Prof Ian de Boer (Washington, US), Prof Peter Rossing (Copenhagen, DK) and Prof Shelley Zieroth (Winnipeg, CA) lead an interactive programme of plenary sessions, meet the expert, case discussions and satellite symposium sessions focusing on the patient journey.

 

For the first time, e-SPACE Cardio-Renal-Metabolic 2023 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, alongside KDIGO's mission to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.


 

e-SPACE Cardio-Renal-Metabolic 2023 would like to thank the following sponsors:

Learning Objectives

  • Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality, and reduced quality of life affecting individuals around the world
  • Describe the complexity and interlink between the three conditions
  • Discuss existing guidelines and best approaches for screening patients
  • Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease & obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies
  • Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes

Target Audience

  • Cardiologists
  • Nephrologists
  • Diabetologists
  • General Practitioners (GPs)
  • HF Specialists
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

More from this programme

Part 1

Day One

10 sessions
Plenary session 1 – HFpEF Watch now
Satellite symposium – SGLT2 inhibitors in cardio-renal-metabolic patients – the perfect fit? (Supported by an educational grant from the Boehringer Ingelheim & Lilly Alliance) Watch now
Plenary session 2 – SGLT2 updates Watch now
Meet the expert – Management of heart failure in real world clinical practice – insights from the REWOLUTION HF surveys Watch now
Plenary session 3 – Weight management in CRM disease Watch now
Meet the expert – Implementation patterns and challenges in HF care: insights from the EVOLUTION HF study (Supported by an educational grant from AstraZeneca) Watch now
Plenary session 4 – Guidelines implementation for acutely ill patients Watch now
Plenary session 5 – Mineralocorticoids antagonists in CRM disease Watch now
Meet the expert – Single pill combination (SPC) in Cardiorenal metabolic (CRM) disease Watch now
Plenary session 6 – Diuretics: old drugs, new data, new approaches Watch now

Part 2

Day Two

9 sessions
Plenary session 7 – CRM drug management in patients with low eGFR and type 2 diabetes Watch now
Satellite symposium – Management of CKD without diabetes – SGLT2 inhibitors, the new standard of care (Supported by an educational grant from AstraZeneca) Watch now
Plenary session 8 – Diabetes and cardio-renal disease: the relevance of early treatment with the right drug Watch now
Meet the expert – Management of hyperkalemia in cardiorenal disease ‒ practical guidance and novel therapeutic options (Supported by an unrestricted educational grant by CSL Vifor) Watch now
Plenary session 9 – Managing “metals” Watch now
Satellite symposium – Management of hyperkalemia across the cardiorenal spectrum (Supported by an educational grant from AstraZeneca) Watch now
Plenary session 10 – Management of diabetes with kidney disease Watch now
Plenary session 11 – Managing frail and elderly patients Watch now
Plenary session 12 – Managing end-stage disease: focus on QoL Watch now

Faculty Biographies

Gianluigi Savarese

Gianluigi Savarese

Associate Professor of Cardiology

Dr Gianluigi Savarese is currently an Associate Professor of Cardiology and Heart Failure Specialist at the Karolinska Institute in Stockholm, Sweden. 

Dr Savarese has served on the board for the European Society of Cardiology's Heart Failure Association since 2020, and has previously been a Nucleus member of a working group on Cardiovascular Pharmacotherapy for the ESC. He is a member of the Italian Society of Cardiology, and the Swedish Society of Cardiology. 

Dr Savarese attended the University of Naples Federico II University for his degree in Surgery and Medicine between 2004 - 2010. He then went on to stay at the same institution until 2016 as he completed his Specialism in Cardiovascular Diseases. He then continued his postgraduate studies at the University of Zurich between 2015-2017, where he continued his studies into Heart Failure. Finally, Dr Savarese completed his PhD at the Karolinska Institutet in 2018. 

Dr Savarese…

View full profile
Jolanta Małyszko

Jolanta Małyszko

Department and Clinic of Nephrology, Dialysis and Internal Medicine

Prof Jolanta Małyszko works in the Department and Clinic of Nephrology, Dialysis and Internal Medicine at Medical University of Warsaw, Warsaw, PL.

 

View full profile

Comments

You must be to comment. If you are not registered, you can register here.